Isofol Medical Share Issue Oversubscribed, Securing Over SEK 39 Million to Strengthen the Ongoing Phase II Clinical Development Program of Modufolin®
Gothenburg, Sweden (ots/PRNewswire) - Isofol Medical AB, a clinical stage pharmaceutical company, developing novel products for unmet needs within oncology, will use the investment to support the clinical program with Modufolin®, Isofol's lead drug candidate. Modufolin® is a novel folate-based compound being ...